A Cross-Sectional Study on Burden of Hepatitis C, Hepatitis B, HIV and Syphilis in Multi-Transfused Thalassemia Major Patients Reporting to a Government Hospital of Central India
Tóm tắt
Need for frequent blood transfusions exposes thalassemia major patients to risk of transfusion-transmitted infections (TTIs). Screening of donor blood through national protocols for possible infections like hepatitis B and C, HIV, syphilis and malaria is considered the optimal preventive method. There is constant need to explore the effect of currently used protocols of blood-donor screening by determining the burden of TTIs in multi-transfused patients. The current study was conducted to determine the burden of TTIs among multi-transfused Thalassemia patients registered at a Government hospital of central India. Sixty-six multi-transfused Thalassemia patients reporting during a period of eight months were screened for hepatitis B and C, HIV as well as syphilis by using standard diagnostic tests. Selected clinical, socio-demographic and other characteristics were also recorded to understand the determinants of risks of these infections. The sero-prevalence of hepatitis B, hepatitis C, HIV and syphilis was 3.0, 18.2, 1.5 and 0 % respectively amongst the patients. Vaccination against hepatitis B was found to be protective. Majority of the infected patients had history of transfusion from non government blood banks. There is a considerable burden of Hepatitis C among multi-transfused Thalassemia patients. The currently used screening tests need to be revalidated or replaced to prevent false-negative diagnoses. All sectors need to optimally implement and control both, the quality of blood donors and the mandatory screening of blood and blood products against the TTIs along with prospective longitudinal data and follow up of patients.
Tài liệu tham khảo
Remesar M, Gamba C, Kuperman S, Marcosa MA, Miguez G, Caldarola S et al (2005) Antibodies to hepatitis C and other viral markersin multi-transfused patients from Argentina. J Clin Virol 34(Suppl 2):S20–S26
Laguna-Torres VA, Pérez-Bao J, Chauca G, Sovero M, Blichtein D, Chunga A et al (2005) Epidemiology of transfusion-transmitted infections among multi-transfused patients in seven hospitals in Peru. J Clin Virol 34(Suppl 2):S61–S68
Ballester JM, Rivero RA, Villaescusa R, Merlín JC, Arce AA, Castillo D et al (2005) Hepatitis C virus antibodies and other markers of blood-transfusion-transmitted infection in multi-transfused Cuban patients. J Clin Virol 34(Suppl 2):S39–S46
Spiliopoulou I, Arvaniti A, Kolonitsiou F, Dimitracopoulos G, Athanassiadou A (1995) Beta-thalassaemia and the prevalence of HCV viraemia. Haematologia (Budap) 27(1):15–22
Government of India. Ministry of health and family welfare. Department of health. Schedule F. The Drugs and Cosmetics Act, 1940 and the Drugs and Cosmetics Rules, 1945, as amended up to 30th June, 2005. Part XIIB. p. 326. Available from http://www.cdsco.nic.in/DrugsandCosmeticAct.pdf. [Last accessed on 2013 January 16]
Kumar S (1996) Indian Supreme Court demands cleaner blood supply. Lancet 347(8994):114
Ray VL, Chaudhary RK, Choudhury N (2000) Transfusion safety in developing countries and the Indian scenario. Dev Biol (Basel) 102:195–203
Narayan S (2001) Microbes and blood transfusion. Indian J Med Microbiol 19:119–126
Sen S, Mishra NM, Giri T, Pande I, Khare SD, Kumar A et al (1993) AIDS in multitransfused children with thalassemia. Indian Pediatr 30:455–460
Kapoor D, Saxena R, Sood B, Sarin SK (2000) Blood transfusion practices in India: results of a national survey. Indian J Gastroenterol 19(2):64–67
Kumar N, Shekhar C, Kumar P, Kundu AS (2007) Kuppuswamy’s socioeconomic status scale-updating for 2007. Indian J Pediatr 74(12):1131–1132
Wonke B, Hoffbrand AV, Brown D, Dusheiko G (1990) Antibody to hepatitis C virus in multiply transfused patients with thalassaemia major. J Clin Pathol 43(8):638–640
Amarapurkar DN, Kumar A, Vaidya S, Murti P, Bichile SK, Kalro RH, Desai HG (1992) Frequency of hepatitis B, C and D and human immunodeficiency virus infections in multi-transfused thalassemics. Indian J Gastroenterol 11(2):80–81
Karimi M, Ghavanini AA (2001) Seroprevalence of hepatitis B, hepatitis C and human immunodeficiency virus antibodies among multitransfused thalassaemic children in Shiraz, Iran. J Paediatr Child Health 37(6):564–566
Mollah A, Nahar N, Siddique M, Anwar K, Hassan T, Azam MG (2003) Common trasfusion-transmitted infectious agents among thalassaemic children in Bangladesh. J Health Popul Nutr 21:67–71
Mirmomen S, Alavian SM, Hajarizadeh B, Kafaee J, Yektaparast B, Zahedi MJ et al (2006) Epidemiology of HBV, HCV, HIV in pts. with beta thalassemia major––in Iran a multicentric study. Arch Intern Med 9:319–323
Samimi-Rad K, Shahbaz B (2007) Hepatitis C virus genotypes among patients with thalassemia and inherited bleeding disorders in Markazi province, Iran. Haemophilia 13(2):156–163
Shah N, Mishra A, Chauhan D, Vora C, Shah NR (2010) Study on effectiveness of transfusion program in thalassemia major patients receiving multiple blood transfusions at a transfusion centre in Western India. Asian J Transfus Sci 4(2):94–98
Vidja PJ, Vachhani JH, Sheikh SS, Santwani PM (2011) Blood transfusion transmitted infections in multiple blood transfused patients of Beta thalassaemia. Indian J Hematol Blood Transfus 27(2):65–69
Ataei B, Hashemipou M, Adib P, Kassaian N, Hassannejad R, Nokhodian Z (2012) Prevalence of anti HCV infection in patients with Beta-thalassemia in Isfahan-Iran. Int J Prev Med 3(suppl 1):S118–S123
Mathew JL, El Dib R, Mathew PJ, Boxall EH, Brok J (2008) Hepatitis B immunisation in persons not previously exposed to hepatitis B or with unknown exposure status. Cochrane Database Syst Rev (3): CD006481
Soldan K, Barbara JAJ, Ramsay ME, Hall AJ (2003) Estimation of the risk of hepatitis B virus, hepatitis C virus and human immunodeficiency virus infectious donations entering the blood supply in England, 1993–2001. Vox Sang 84(4):274–286
Roth WK, Busch MP, Schuller A, Ismay S, Cheng A, Seed CR et al (2012) International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009. Vox Sang 102:82–90
Makroo RN, Choudhury N, Jagannathan L, Parihar-Malhotra M, Raina V, Chaudhary RK et al (2008) Multicenter evaluation of individual donor nucleic acid testing (NAT) for simultaneous detection of human immunodeficiency virus -1 & hepatitis B & C viruses in Indian blood donors. Indian J Med Res 127:140–147
Jain R, Aggarwal P, Gupta GN (2012) Need for nucleic acid testing in countries with high prevalence of transfusion-transmitted infections. ISRN Hematol 2012:718671
Chatterjee K, Coshic P, Borgohain M, Premchand, Thapliyal RM, Chakroborty S et al (2012) Individual donor nucleic acid testing for blood safety against HIV-1 and hepatitis B and C viruses in a tertiary care hospital. Natl Med J India 25:207–209
Punde RP, Bhargava A, Varshney S, Pathak N, Shrivastava M, Mishra PK (2014) Ascertaining the prevalence of occult hepatitis B virus infection in voluntary blood donors: a study from Central India. Indian J Pathol Microbiol 54:408
Bhargava A, Pathak N, Varshney S, Shrivastava M, Mishra PK (2014) Molecular detection of window phase hepatitis C virus infection in voluntary blood donors and health care workers in a cohort from Central India. Indian J Community Med 39:51–52